Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis
Status:
Completed
Trial end date:
2018-06-23
Target enrollment:
Participant gender:
Summary
The main objective of this study is to describe the pharmacokinetics of the prescribed
echinocandins for septic shock with secondary peritonitis for which intra-abdominal fungal
infection is suspected or proven.